Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Enterprise Value: 2024-2025

Historic Enterprise Value for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $218.5 million.

  • Kura Oncology's Enterprise Value fell 79.03% to $218.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.8 billion, marking a year-over-year decrease of 220.06%. This contributed to the annual value of -$50.1 million for FY2024, which is 104.69% down from last year.
  • Latest data reveals that Kura Oncology reported Enterprise Value of $218.5 million as of Q3 2025, which was up 266.54% from -$131.2 million recorded in Q2 2025.
  • Kura Oncology's 5-year Enterprise Value high stood at $1.1 billion for Q1 2024, and its period low was -$131.2 million during Q2 2025.